Screener
Xeris Biopharma Holdings, Inc. XERS Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $1.37B.
The source filing: Xeris Biopharma Holdings, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001867096-26-000065
FAQ
- What is Xeris Biopharma Holdings, Inc.'s market capitalization?
- Xeris Biopharma Holdings, Inc. (XERS) reported market capitalization of $1.37B in Q2 2026.
- How has Xeris Biopharma Holdings, Inc.'s market capitalization changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s market capitalization increased by 83.2% year-over-year, from $746.32M to $1.37B.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s market capitalization has grown at a 16.2% compound annual growth rate (CAGR), from $613.57M to $1.3B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Xeris Biopharma Holdings, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude